Oscar Health (NYSE:OSCR) Shares Gap Up – Time to Buy?

Shares of Oscar Health, Inc. (NYSE:OSCR) gapped up prior to trading on Monday . The stock had previously closed at $13.48, but opened at $16.25. Oscar Health shares last traded at $16.6650, with a volume of 18,156,879 shares.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Wells Fargo & Company dropped their price objective on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a report on Thursday, November 13th. Wall Street Zen upgraded Oscar Health from a “sell” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a research note on Wednesday, October 8th. Piper Sandler cut their price target on Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Finally, Zacks Research raised Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Six investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Reduce” and a consensus price target of $13.14.

Oscar Health Price Performance

The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. The firm’s 50-day moving average price is $18.26 and its 200-day moving average price is $16.92. The stock has a market capitalization of $4.43 billion, a PE ratio of -14.87 and a beta of 1.88.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. During the same quarter last year, the business posted ($0.22) earnings per share. The firm’s revenue was up 23.2% on a year-over-year basis. Oscar Health has set its FY 2025 guidance at EPS. On average, equities analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 395,000 shares of the business’s stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the transaction, the insider owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. CIBC Bancorp USA Inc. purchased a new stake in shares of Oscar Health in the third quarter valued at $392,000. EMC Capital Management grew its holdings in Oscar Health by 336.7% during the 3rd quarter. EMC Capital Management now owns 13,100 shares of the company’s stock valued at $248,000 after purchasing an additional 10,100 shares during the last quarter. Advisory Services Network LLC grew its holdings in Oscar Health by 390.1% during the 3rd quarter. Advisory Services Network LLC now owns 39,235 shares of the company’s stock valued at $743,000 after purchasing an additional 31,229 shares during the last quarter. Marathon Asset Management LP raised its position in Oscar Health by 66.7% in the 3rd quarter. Marathon Asset Management LP now owns 75,000 shares of the company’s stock worth $1,420,000 after purchasing an additional 30,000 shares during the period. Finally, Jacobs Levy Equity Management Inc. lifted its stake in Oscar Health by 31.0% in the third quarter. Jacobs Levy Equity Management Inc. now owns 303,603 shares of the company’s stock worth $5,747,000 after purchasing an additional 71,932 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.